A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
This study evaluates the addition of Tenofovir and Entecavir in the treatment of Hepatitis B-related hepatocellular carcinoma after curative resection in adults. Half of participants will receive Tenofovir disoproxil fumarate, while the other half will receive Entecavir.
Epistemonikos ID: 30eefa0dd28f0c6d3b819d59a1ca90a284bc8f19
First added on: Nov 24, 2021